UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Osprey Private Wealth LLC

Osprey Private Wealth LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 17.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,675 shares of the healthcare conglomerate’s stock after purchasing an additional 835 shares during the quarter. UnitedHealth Group makes up 2.0% of Osprey Private Wealth LLC’s investment portfolio, making the stock its 20th largest position. Osprey Private Wealth LLC’s holdings in UnitedHealth Group were worth $2,871,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also modified their holdings of the company. Kathleen S. Wright Associates Inc. acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at $27,000. West Financial Advisors LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth $32,000. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth $30,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth $37,000. Finally, Friedenthal Financial acquired a new stake in UnitedHealth Group during the 3rd quarter worth $51,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Stock Down 0.6 %

Shares of NYSE UNH opened at $545.08 on Wednesday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm’s 50 day moving average price is $535.03 and its 200 day moving average price is $565.09. The firm has a market cap of $501.63 billion, a P/E ratio of 35.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the business earned $5.83 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on UNH shares. Royal Bank of Canada cut their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Stephens raised their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a report on Friday, January 10th. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.